Biand tricyclic substituted phenyl methanones as glycine transporter I (GlyT-1) inhibitors for the treatment of Alzheimer's disease

Details for Australian Patent Application No. 2005315914 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Norcross, Roger David; Pinard, Emmanuel; Narquizian, Robert; Jolidon, Synese

Agent Spruson & Ferguson

Pub. Number AU-B-2005315914

PCT Pub. Number WO2006/063709

Priority 04106597.0 15.12.04 EP

Filing date 5 December 2005

Wipo publication date 22 June 2006

Acceptance publication date 3 March 2011

International Classifications

C07D 495/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms

A61K 31/4365 (2006.01)

A61K 31/437 (2006.01)

A61K 31/4985 (2006.01) - Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

C07D 513/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or

Event Publications

28 June 2007 PCT application entered the National Phase

  PCT publication WO2006/063709 Priority application(s): WO2006/063709

2 August 2007 Change of Name(s) of Applicant(s), Section 104

  F.Hoffmann-La Roche AG The name of the applicant has been changed to F. Hoffmann-La Roche AG

3 March 2011 Application Accepted

  Published as AU-B-2005315914

30 June 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005315919-Pharmaceutical compositions for the treatment of cellulite

2005315913-Tetracyclic imidazo-benzodiazepines as GABA receptors modulators